Calmare Therapeutics Inc (fka CTTC)

[kakalak]

Hey, conix. Do you have any idea when the data comes out of Masssey Center? I am from VA and I know the Massey Center--very respected cancer center. I would be surprised if Massey would get snookered into doing a study on Chemotherapy caused pain from a schlock company. PThe proof is in the pudding, but if the data shows that this device has a big market in the oncology market, CTT will be attracting more institutions, IMO.

The Seeking Alpha report does give an impressive list of why getting a few shares soon makes sense, in my view:

---CTT has only 10.12 Million shares outstanding, giving the company a market cap of only $20.5 Million

---Five (5) corporate insiders--the CEO and four directors-- added to their CTT stock positions two weeks ago

---Institutional Ownership (mutual and pension funds and money managers) of CTT has risen to 8.9% of the shares outstanding
Company signed a contract with a U.S. distributor which brings over $1 Million in payments over the next 8 months (from August, 2009)

---A sales contract announced last month obligates the customer to purchase a minimum of 20 of CTT's pain therapy medical devices over the next 13 months

---CTT shipped 17 units last quarter with another 53 units on order and to be shipped most likely in this quarter (ending Jan. 31, 2010)--which would represent a 311% quarter to quarter growth in sales

---Clinical data from patients suffering from Chemotherapy-Induced Peripheral Neurapathy (CIPN) that use CTT's medical device is expected soon, offering more media coverage opportunities for the company

Have a great weekend, everybody